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Abstract 
Background: Echocardiography and the N-terminal pro-brain-type natriuretic peptide (NT-proBNP) level are impor-
tant tests for assessing left ventricular function in patients presenting to the emergency department with acute 
dyspnea. Chest ultrasound is becoming an important tool in diagnosing acute pulmonary edema.
Aim: To assess the diagnostic accuracy of chest ultrasound examination using echocardiography and a curvilinear probe 
for detecting B-lines in patients presenting with acute pulmonary edema compared with assessment using NT-proBNP.
Methods: This paper reports a prospective observational study of 61 consecutive patients presenting with symp-
toms and signs of pulmonary edema and B-profile detected by echocardiography with a 5 MHz curvilinear probe. 
The emergency department physicians ordered NT-proBNP levels, and critical care physicians trained in ultrasound 
examination performed echocardiography and chest ultrasounds. The findings of the chest ultrasound were reviewed 
by another senior physician.
Results: Sixty-one participants were enrolled over a period of 6 months (49.2 % male, with a mean age 66.8). 
Forty-seven of the 61 patients had a B-profile. The median NT-proBNP level in the patients with B-profile was 6200, 
compared with the mean level in the patients with an A-profile of 180 (CI 0.33–0.82). The distributions in the two 
groups differed significantly (p = 0.034). Based on a threshold level of NT-proBNP in relation to age, the sensitivity and 
specificity (including the 95 % confidence interval) were determined; the sensitivity of finding B-profile on ultrasound 
was 92.0 %, and the specificity was 91.0 %. The positive predictive value of the B-profile was 97.0 %, and the negative 
predictive value was 71.0 %. The systolic function in the subjects with a B-profile was below 50 in 84.3 % of the sub-
jects and normal in 15.7 % of the subjects. An A-profile was present in all of the subjects with systolic function >55 %. 
In the subjects with a B-profile, 94 % had a Framingham score of CHF >4; the subjects with all A-profile had scores <4, 
p < 0.0001. There was an NHANES score of >3 in 96 % of the subjects with a B-profile, and all of the subjects with an 
A-profile had scores <3 (p < 0.0001).
Conclusions: Detecting the B-profile with an echocardiography probe (curvilinear 5 MHz) in lung ultrasound is 
highly sensitive and specific for elevated NT-proBNP helping in diagnosing pulmonary edema, although of resolution 
inferior to micro convex probes.
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Background
Acute pulmonary edema is a common problem facing 
emergency department (ED) physicians, and a percentage 
of these patients are admitted to a CCU. The diagnosis of 
acute pulmonary edema remains a challenge for the fol-
lowing reasons: the presentation could be in combination 
with other diseases, such as chronic obstructive airway 
disease; and other diseases have a presentation that is 
similar to that of acute pulmonary edema.
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Cardiologists and intensivists commonly assess the 
heart using echocardiography. To save time, an extended 
evaluation could be performed using the same probe to 
complete the evaluation without changing the probe. 
Chest ultrasound is used to detect subpleural inter-
stitial edema lines (B-lines) and pleural effusion; this 
method is used to exclude other important diseases, e.g., 
pneumothorax.
The assay for plasma ProBNP is a useful test for the 
evaluation of patients with dyspnea, and it is particularly 
useful as a component of the evaluation of a suspected 
heart failure when the diagnosis is uncertain [1].
The correlation between ProBNP and B-lines was 
studied using a linear probe. To simplify and expedite 
the procedure, we correlated the B-lines detected by the 
echocardiography probe to the NT-proBNP assay.
Methods
Study design
This work was a prospective, blinded observational study 
of an enrolled sample of ED patients in whom the ED 
physician requested NT-proBNP.
Population and setting
The study was performed in the Ahmadi hospital ED and 
CCU. The hospital is a subsidiary of Kuwait Oil Company 
(KOC). The hospital serves KOC members and their 
families, including their parents, with annual ED census 
of 60,000 visits. US examinations are currently used in 
daily practice in the ED, CCU, and ICU of this hospital.
Patients were included if they were >18 years old and 
had acute dyspnea, and if the treating ED physician’s 
clinical suspicion that acute pulmonary edema and left 
ventricular failure was part of the differential diagnosis 
after the history and physical examination and before 
any testing was completed or a serum NT-proBNP was 
ordered in the ED. Clinical data were entered onto a 
separate standardized data collection form at the time 
of enrollment by the treating ED physician who was 
blinded to the ultrasound results. Clinical data included 
the patients’ age and sex, presenting symptoms, medi-
cal history, and physical examination findings, oxygen 
saturation from pulse oximetry and chest radiograph as 
listed in Table 1. For patients with a diagnosis other than 
left ventricular failure, confirmation was attempted using 
normal chest radiograph findings (absence of cardio-
megaly or pulmonary venous congestion); radiographic 
signs pneumonia, or lung cancer. The ED physician were 
presented with the components and a summary of the 
Framingham scores for congestive heart failure (two 
major, or one major and two minor criteria), and the 
National Health and Nutrition and Examination Sur-
vey (NHANES) heart failure score (≥3) calculated from 
the case report form along with other information from 
the emergency department data sheets. We excluded 
patients if they were non-KOC members because the 
follow-up would be in other hospitals in Kuwait. Addi-
tionally, we excluded patients who were incapable of 
providing informed consent.
Protocol
Each patient underwent an 8-zone thoracic ultrasound. 
The treating physician in the ED obtained informed writ-
ten consent as well as baseline demographic and clinical 
data. Ultrasound scans were performed by a physician 
trained in the techniques of chest ultrasound and echo-
cardiography. The ultrasound images were saved to a 
hard drive and reviewed in the system by a senior inten-
sivist trained in critical care ultrasound. The physicians 
were blinded to the NT-proBNP results.
Ultrasound was performed using portable echocardi-
ography (GE Vivid S6N, N-3191 Horten, Norway) equip-
ment with a 5-MHz broadband curvilinear transducer in 
the echocardiography preset.
The exams consisted of bilateral scanning of the ante-
rior and lateral chest wall and were performed with the 
patients in the supine or near-to-supine position. The 
correct scan was intercostal with the maximum exten-
sion of the visible pleural line. The chest wall was divided 
into eight areas, and scans for each area were obtained. 
The areas included two anterior and two lateral regions 
per side. The anterior chest wall was delineated from the 
sternum to the anterior axillary line and was subdivided 
into upper and lower halves (approximately from the 
clavicle to the second-third intercostal spaces and from 
the third intercostal space to the diaphragm). The lateral 
zone was delineated from the anterior to the posterior 
axillary line and was subdivided into upper and basal 
halves. The probe was placed in a cephalic orientation, 
and the pleural line was placed in the middle of the image 
by adjusting the depth settings [2].
Measurements
The two primary findings on thoracic ultrasound are 
A-lines and B-lines. AB-line is a comet tail artifact that 
arises from the pleural line and moves in concert with 
lung sliding. It is long, well-defined, laser-like, and hyper-
echoic and it erases A-lines [2]. The updated definition of 
B-line requires three constant criteria (comet tail, aris-
ing from pleural line and moving with lung sliding) and 
four quite constant criteria (long, well-defined, hyper-
echoic, and erasing A-line) [3]. An A-line is the repetition 
of the pleural line, and it is an approximately horizon-
tal hyperechoic line parallel to the pleural line [2]. Two 
important profiles are detected, as follows: the A-profile 
(Fig. 1) associates anterior lung sliding with A-lines, and 
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the B-profile (Fig. 2) is defined by the presence of three or 
more B-lines in a longitudinal plane between two ribs per 
scan area, diffuse B-lines in more than one scan per side, 
and the presence of B-lines in both sides, associates ante-
rior lung sliding [4]. 
Data analysis
The statistical analyses were performed using SPSS 
19. We determined the median Pro BNP value for the 
patients with A-profile and B-profile and calculated 95 % 
confidence intervals (CI) of the difference.
The evaluation of the data was performed with the 
Mann–Whitney U test to delineate the significance of 
the difference in the rank order of NT-proBNP in the 
patients with A-profile and B-profile.
The NT-proBNP level was considered positive at 
the threshold limit in relation to age. For age <50, the 
threshold limit for being positive was 450  pg/mL, for 
age 50–75, the level was 900, and for age >75, the level 
was 1800 pg/mL. A level below 300 excludes a diagnosis 
of heart failure with a negative predictive value of 80 % 
[5].
To increase the sensitivity of B-lines and chest ultra-
sound in cases of elevated NT-proBNP to reach a 
diagnosis in patients with dyspnea, we included the 
HANES criteria for the diagnosis of heart failure and 
the ejection systolic function (EF) when performing the 
echocardiography.
Results
We enrolled 61 patients over a period of 6  months. 
The patients provided signed consent. The mean age 
was 66.8 years, with a range of 44–93 years; 49.2 % of 
the subjects were male. A total of forty-seven of the 
61 patients had B-profile and hemodynamic pulmo-
nary edema. The clinical characteristics of the patients 
in relation to ultrasound chest profiles are shown in 
Table 1.
Table 1 The clinical characteristics of the patients in relation to ultrasound chest profiles
a Two major (one point each) or one major and two minor (0.5 point each) criteria
b National health and nutrition examination survey
A-profile no (%) B-profile no (%) Total no (%) p
Medical history
 Myocardial infarction 0 (0.0) 37 (72.5) 60.7 (37) <0.0001
 Angina 3 (30.0) 27 (52.9) 30 (49.2) 0.164
 Coronary artery bypass 0 (0.0) 12 (23.5) 12 (19.7) 0.091
Graft
 Atrial fibrillation 0 (0.0) 10 (19.6) 10 (16.4) 0.142
 Hypertension 6 (60.0) 45 (88.2) 51 (83.6) 0.049
 NIDDM 7 (70.0) 45 (88.2) 52 (85.2) 0.99
 IDDM 3 (30.0) 6 (11.8) 9 (14.8) 0.157
 Asthma 2 (20.0) 3 (5.9) 5 (8.2) 0.185
 Obstructive airway disease 4 (40.0) 6 (11.8) 10 (16.4) 0.49
 Chronic renal impairment 1 (10.0) 23 (45.1) 24 (39.3) 0.037
Clinical examination
 Shortness of breath 12 (91) 45 (95.7) 57 (93.4) 0.02
 Elevated jugular venous pressure 2 (14) 33 (70) 35 (57) <0.0001
 Pulmonary rales 4 (28) 29 (61.7) 33 (54) <0.0001
 Wheezing 5 (30) 13 (28) 18 (29.5) 0.85
 S3 gallop 2 (14) 35 (74.4) 37 (60.6) <0.0001
 Hypoxemia 12 (85.7) 43 (89) 55 (90) 0.02
 Chest radiograph findings
 Normal heart size 11 (78.5) 11 (23.4) 22 (36) <0.0001
 Pulmonary venous congestion 2 (14) 43 (89) 45 (73.7) <0.0001
 Interstitial edema 1 (7) 40 (85) 41 (67) <0.0001
 Alveolar edema 1 (7) 40 (85) 41 (67) <0.0001
Heart failure scores
 Framingham scorea > 2 0 (0) 47 (94) 47 (78.3) <0.0001
 NHANES scoresb > 3 0 (0) 48 (96) 48 (80) <0.0001
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The analysis revealed that A-profile was present in all 
of the patients with a NT-proBNP <400 or 300  pg/mL. 
Fifty of the 61 patients had elevated ProBNP levels in 
relation to age (Table 2).
The median NT-proBNP levels in patients with B-pro-
file was 6200, compared with a median of 180 in the sub-
jects with A-profile (CI 0.33–0.82).
The distributions in the 2 groups differed significantly 
(Mann–Whitney U-static 3.98). Based on the threshold 
level of NT-proBNP of 250, the sensitivity of detecting 
B-profile on ultrasound was 95.0  %, and the specificity 
was 92.0 %. The positive predictive value of the B-profile 
was 90.0 %, and the negative predictive value was 88.0 % 
(Table 2).
The systolic function in the subjects with a B-profile 
was below 50 % in 84.3 % of cases and normal in 15.7 % 
of cases. The subjects with an A-profile all had systolic 
function >55 %.
Of those subjects with a B-profile, 94 % had a Framing-
ham score of CHF >4; all of the subjects with an A-profile 
had a score of <4, p < 0.0001. National Health and Nutri-
tion Examination Survey (NHANES) scores of >3 were 
found in 96 % of those with a B-profile, and all of the sub-
jects with an A-profile had scores <3, p < 0.0001.
Discussion
Lung ultrasound is becoming an essential tool for the 
diagnosis of pulmonary disease irrespective of the 
echocardiographic findings. This method is becom-
ing a standard method to complement conventional 
Doppler echocardiography in the rapid evaluation of 
patients presenting with dyspnea in the emergency 
department (for the differential diagnosis of dysp-
nea), in hospital management (for serial evaluations 
in the same patient and for tailoring diuretic therapy), 
in the prehospital emergency setting (with hand-held 
Table 2 Chest ultrasound profiles based on  N-terminal 
pro-brain-type natriuretic peptide
LR+ positive likelihood ratio, LR− negative likelihood ratio
Thoracic ultrasound 
profile
proBNP positive in 
relation to age
Negative proBNP Total
B-profile 46 1 47
A-profile 4 10 14
Total 50 11 61




Positive predictive value 0.97 0.889–0.996
Negative predictive value 0.714 0.454–0.883
LR+ 10.12 1.559–65.697
LR− 0.088 0.034–0.229
Fig. 2 B-profile. Pleural line (large arrows) and here three B-lines 
(small arrows). Lung sliding, fully part of the definition of the B-profile, 
is not featuring here. R is acoustic rib shadow
Fig. 1 A-profile, pleural line (small arrow) visible between two ribs. 
Roughly horizontal parallel reverberation lines (large arrows). A-lines, 
shown in the figure, must be associated with lung sliding
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echocardiography), and in the stress echocardiogra-
phy lab (as a sign of acute pulmonary congestion dur-
ing stress) [4].
Providing a reliable and repeatable estimation of 
EVLW, B-profile assessment by lung ultrasound repre-
sents a new, helpful tool for the cardiologist; this tool 
could be employed at all stages of the management of 
heart failure patients and could be used in the differential 
diagnosis of dyspnea [4, 6].
Increased left ventricular filling pressure is a common 
hemodynamic trigger for natriuretic peptides and B-pro-
file. Wall distension is generally considered the main 
mechanical stimulus for natriuretic peptide production 
by ventricular tissue from stretched cardiomyocytes [7]. 
The use of NT-proBNP and B-type natriuretic peptide at 
the rule-out threshold recommended by the recent Euro-
pean Society of Cardiology guidelines on heart failure 
provides excellent ability to exclude acute heart failure 
in the acute setting with reassuringly high sensitivity [8]. 
The specificity of the natriuretic peptides is modest and 
variable, and therefore confirmatory diagnostic testing by 
cardiac imaging is required in the case of positive results 
[8].
The presence of B-profile as a sign of pulmonary inter-
stitial edema is linked to augmented left ventricular fill-
ing pressures, which unbalance Starling forces at the 
alveolar–capillary barrier, resulting in pulmonary con-
gestion [9]. Therefore, the overall good concordance and 
significant correlation between B-lines and NT-proBNP 
found in this study are not surprising.
The presence of B-profile correlating with higher 
BNP levels were previously studied using a linear probe 
because this method is easily learned and reproducible 
[10]. Although earlier literature identified similar results 
with curved probes [11], we used a curved probe in this 
study to allow for extended echocardiography exami-
nations of the patient’s heart and chest using the same 
probe. The use of an echocardiography probe in detecting 
B-profile in the bedside evaluation of patients with known 
or suspected heart failure by experienced and inexpe-
rienced echocardiologists was previously studied and 
shown to be a reliable diagnostic tool [12]. Cardiac probes 
can show lung artifacts, may be with a quality inferior to 
some other equipment. We used an 8-zone scanning pro-
tocol compared with an NT-proBNP, and we detected 
that minimal pleural effusion corresponded more closely 
with heart failure in cases in which the patient presented 
with acute dyspnea. An eight-lung window protocol was 
used in the studies by Liteplo et al [11] and Volpicelli et al 
[2]. Lichtenstein et al. used a six-window protocol in pre-
vious studies and included the PosteroLateral Alveolar 
and/or Pleural Syndrome (PLAPS)-point, a posterior area 
accessible in supine patients, locating all free effusions, 
regardless of their volume [4].
In the literature, there have not been stringent criteria 
defining how many B-lines constitute a significant lung 
ultrasound finding. Lichtenstein et al. first used the pres-
ence of at least three B-lines per field of scan seen longi-
tudinally between two ribs, with a distance between two 
B-lines <7 mm, as criteria for abnormality, and the major-
ity of authors have followed this convention (1, 2, 10, 13). 
These criteria have been used irrespective of the scan 
technique, whether the scan is transverse in the intercos-
tal space or longitudinal across ribs. Typically, a micro 
convex or phased array probe with a narrow footprint is 
used. Some operators decide to use a linear or curvilin-
ear probe with a broad footprint. These probes allow for 
views across several rib spaces or for a longer view of the 
pleural line. A positive scan with these probes should be 
similar to the general convention of at least three B-lines 
less than 7 mm apart [14].
The presence of B-profile is specific for an elevated NT-
proBNP level although the sensitivity is variable [15]. In a 
linear probe study, the sensitivity was 33.3 %. B-lines had 
a sensitivity of 100 % and a specificity of 92 % in the diag-
nosis of pulmonary edema when compared with COPD 
[16]. Gargani L et  al. used a cardiac probe and deter-
mined that B-lines are reliable in predicting the cardio-
genic origin of dyspnea, with an accuracy comparable to 
natriuretic peptides [13].
The echocardiographic data appear useful in the con-
text of a lung ultrasound examination, given the high 
accuracy published in previous articles (Sensitivity 97 %, 
specificity 95 %) [3]. B-profile could be a plausible alter-
native in acute settings where natriuretic peptide analy-
sis is not available or when there is insufficient time to 
perform the assay, as occurs in patients with rapidly 
developing acute respiratory failure. The estimated time 
in getting the result of NT-proBNP after sampling of the 
patient is almost 3 h in our institute.
The presence of B-profile correlated well with the clin-
ical scores of heart failure in our study. A total of 94  % 
of the patients with a B-profile had a Framingham score 
of CHF >4, and 96 % had NHANES scores of >3. All of 
the patients with A-profile had normal scores. Our study 
demonstrates the clinical correlation of chest ultrasound 
examinations with heart failure scores, as showed previ-
ously in the BLUE-protocol study [3].
Chest sonography focused on B-profile when combined 
with a comprehensive echocardiography study could eval-
uate systolic and diastolic cardiac function [15]. Patients 
with cardiogenic edema are more likely to have a lower 
ejection fraction and a higher degree of diastolic dysfunc-
tion [17]. In our study, 15.4 % of patients with cardiogenic 
Page 6 of 6Bitar et al. Ann. Intensive Care  (2015) 5:56 
pulmonary edema and B-profile had a left ventricular 
ejection fraction (LVEF) >50 % with high NT-proBNP lev-
els, predominantly because of diastolic dysfunction.
Limitations of the study include low number of patients 
recruited. This was due to two main reasons; NT-proBNP 
was ordered by the ED physician on difficult patients 
with high heart failure scores, thus missing patients with 
genuine hemodynamic pulmonary edema. Thus, other 
profiles of BLUE-protocol in our population were not 
included. Furthermore, patients incapable of provid-
ing informed consent, even though having pulmonary 
edema, were omitted from the study. We compared the 
B-profile to the clinical signs of heart failure and to a cor-
relation with natriuretic peptides. Spectral tissue Dop-
pler-derived index(E/E’) for assessing left atrial pressure 
as well as patients having heart failure with preserved 
ejection fraction were not studied, thus considered a lim-
itation to our study.
Conclusion
Detecting the B-profile is highly sensitive and specific 
for elevated NT-proBNP helping in diagnosing pulmo-
nary edema. A cardiac probe (curvilinear 5 MHz) can be 
used, although of resolution inferior to some micro con-
vex probes. Performing chest ultrasound could be part of 
the echocardiography evaluation in patients with acute 
dyspnea.
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